Key caveat from Anthropic: Claude Science is "not a new AI model and not a more capable model for biology. It's the same Claude that we have, but arranged in a workbench specifically for scientists" .

Capabilities

• Unified workspace — Integrates databases, coding tools, compute, and research workflows into a single environment, eliminating the need to bounce between separate tools .
• Pre-configured with 60+ scientific databases — including literature, genomics, chemical, and bioassay datasets .
• Project manager assistant — Helps with literature analysis, computational analysis, figure and manuscript creation, and tracing results back to source code and environment .
• Visual outputs — Generates charts, graphs, and 3D protein structure visualizations .
• Auditable artifacts — All results are traceable to their source code and compute environment, supporting reproducibility .
• Pricing — Forbes reported a test-drive cost of $26 for a full research mapping exercise .

Partnerships and Customer Showcases

• Bristol Myers Squibb was featured as a customer showcase during the event, demonstrating real-world pharmaceutical use of Claude .
• The event included participation from Anthropic leadership, life sciences executives, and leading research institutions .
• The launch follows an 18-month strategy in life sciences, with Zubair Jandali (Anthropic's head of health care and life sciences) having previously described a $400M biotech push .

Competing Products

• OpenAI has been the most direct competitor in this space. It launched OpenAI for Science in October 2025 as a dedicated team , followed by Prism (a free ChatGPT-based research tool using GPT-5.2, launched January 2026) , and GPT-Rosalind (a model for drug development and biology, launched April 2026) .
• Google DeepMind has AlphaFold 3 (with Isomorphic Labs) for protein structure prediction, though during the same week Anthropic hired away four key DeepMind researchers including Nobel laureate John Jumper (AlphaFold lead), Jonas Adler, Alexander Pritzel, and Arthur Conmy .

Related News from the Same Period

• GPT-5.6 "Sol" — OpenAI previewed GPT-5.6 Sol just days earlier (June 27), though this was a general model release, not specifically a science tool .
• Fable 5 return — Anthropic also announced on June 30 that the game Fable 5 would return globally on July 1, along with the release of Claude Sonnet 5, a new frontier model .
• IPO context — The launch was widely framed as part of Anthropic's strategy to expand revenue streams ahead of its planned IPO .

Key caveat from Anthropic: Claude Science is "not a new AI model and not a more capable model for biology. It's the same Claude that we have, but arranged in a workbench specifically for scientists" .

Capabilities

• Unified workspace — Integrates databases, coding tools, compute, and research workflows into a single environment, eliminating the need to bounce between separate tools .
• Pre-configured with 60+ scientific databases — including literature, genomics, chemical, and bioassay datasets .
• Project manager assistant — Helps with literature analysis, computational analysis, figure and manuscript creation, and tracing results back to source code and environment .
• Visual outputs — Generates charts, graphs, and 3D protein structure visualizations .
• Auditable artifacts — All results are traceable to their source code and compute environment, supporting reproducibility .
• Pricing — Forbes reported a test-drive cost of $26 for a full research mapping exercise .

Partnerships and Customer Showcases

• Bristol Myers Squibb was featured as a customer showcase during the event, demonstrating real-world pharmaceutical use of Claude .
• The event included participation from Anthropic leadership, life sciences executives, and leading research institutions .
• The launch follows an 18-month strategy in life sciences, with Zubair Jandali (Anthropic's head of health care and life sciences) having previously described a $400M biotech push .

Competing Products

• OpenAI has been the most direct competitor in this space. It launched OpenAI for Science in October 2025 as a dedicated team , followed by Prism (a free ChatGPT-based research tool using GPT-5.2, launched January 2026) , and GPT-Rosalind (a model for drug development and biology, launched April 2026) .
• Google DeepMind has AlphaFold 3 (with Isomorphic Labs) for protein structure prediction, though during the same week Anthropic hired away four key DeepMind researchers including Nobel laureate John Jumper (AlphaFold lead), Jonas Adler, Alexander Pritzel, and Arthur Conmy .

Related News from the Same Period

• GPT-5.6 "Sol" — OpenAI previewed GPT-5.6 Sol just days earlier (June 27), though this was a general model release, not specifically a science tool .
• Fable 5 return — Anthropic also announced on June 30 that the game Fable 5 would return globally on July 1, along with the release of Claude Sonnet 5, a new frontier model .
• IPO context — The launch was widely framed as part of Anthropic's strategy to expand revenue streams ahead of its planned IPO .